Citius Oncology logo

Citius Oncology

CTOR | NASDAQ
Chart Builder DCF Calculator
$0.54
-$0.03 (-5.89%)
At close: Nov 16, 2026, 4:00 PM ET
$0.54
-$0.01 (-0.93%)
After-hours: Nov 16, 2026, 4:10 PM ET
-5.89%

Rating

Updated: Nov 16, 2026
46.8
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #351/1021 (Top 34%)

Key Statistics

Market Data

Market Cap $58.26M
1D Range
0.53 0.58
52W Range
0.49 1.64

Valuation (TTM)

PE -1.13
PB 1.44
EV/EBITDA -1.20

Valuation (NTM)

Forward PE 7.32
Forward PEG 0.02
Price Target $6.00
Loading financial charts...

Profile

Citius Oncology, Inc. concentrates on advancing innovative, targeted therapeutic solutions for various cancer types. A key aspect of its pipeline includes the development of LYMPHIR, an investigationa...

Sector Healthcare
Employees 285
IPO Date Dec 8, 2022
Fiscal Year October - September

Latest News

No news articles available yet.

Earnings

Next Earnings
Dec 17, 2026
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.